Cart is empty Europe’s drug watchdog on Friday approved the world’s first vaccine for infants against the Respiratory Syncytial Virus, a major cause of child hospitalization on the continent, the Amsterdam-based agency said.
Europe’s drug watchdog on Friday approved the world’s first vaccine for infants against the Respiratory Syncytial Virus, a major cause of child hospitalization on the continent, the Amsterdam-based agency said.
Leave A Comment